Influence of methylphenidate on eating in obese men. (Q44774930)

6 December 2017

title

Influence of methylphenidate on eating in obese men. (English)

1 reference

6 December 2017

0 references

7

Caryn Lerman

1 reference

6 December 2017

1

John J Leddy

1 reference

6 December 2017

6

Gary S Goldfield

1 reference

6 December 2017

Leonard H Epstein

2

1 reference

6 December 2017

Jodie L Jaroni

series ordinal

3

1 reference

6 December 2017

James N Roemmich

series ordinal

4

1 reference

6 December 2017

Rocco A Paluch

series ordinal

5

1 reference

6 December 2017

publication date

1 February 2004

1 reference

6 December 2017

1 reference

6 December 2017

volume

12

1 reference

6 December 2017

issue

2

1 reference

6 December 2017

page(s)

224-232

1 reference

Reinforcing value of food in obese and non-obese women.

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.29

Food reward: brain substrates of wanting and liking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.29

What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.29

Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.29

Dopaminergic agonists normalize elevated hypothalamic neuropeptide Y and corticotropin-releasing hormone, body weight gain, and hyperglycemia in ob/ob mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.29

Evidence that neuropeptide Y and dopamine in the perifornical hypothalamus interact antagonistically in the control of food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.29

Bromocriptine/SKF38393 treatment ameliorates obesity and associated metabolic dysfunctions in obese (ob/ob) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.29

Brain dopamine and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.29

Bupropion SR enhances weight loss: a 48-week double-blind, placebo- controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.29

Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.29

Cardiovascular effects of methylphenidate in humans are associated with increases of dopamine in brain and of epinephrine in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.29

Pharmacotherapy of Adult Attention Deficit/Hyperactivity Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.29

Growth deficits and attention-deficit/hyperactivity disorder revisited: impact of gender, development, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.29

Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.29

ADHD treatment with once-daily OROS methylphenidate: interim 12-month results from a long-term open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.29

Compliance with stimulants for attention-deficit/hyperactivity disorder: issues and approaches for improvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.29

Growth deficits in children treated with desipramine: a controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.29

The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.29

Should we still use the Harris and Benedict equations?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.29

Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.29

Chemosensory function and dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.29

A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.29

Changes in taste and satiety in dietary-restrained women following stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.29

Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct, and oppositional defiant disorder: the additive and subtractive effect of the three dopaminergic genes--DRD2, D beta H, and DAT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.29

21 January 2018

Dopamine genes and ADHD.

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.29

Genotype influences in vivo dopamine transporter availability in human striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.29

Dopamine transporter genotype as a risk factor for obesity in African-American smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.29

Brain dopamine is associated with eating behaviors in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.29

Brain DA D2 receptors predict reinforcing effects of stimulants in humans: replication study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.29

Food intake and the menstrual cycle: a retrospective analysis, with implications for appetite research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.29

Biochemical mechanisms responsible for the attenuation of diabetic and obese conditions in ob/ob mice treated with dopaminergic agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.29

D2 dopamine receptor gene and obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.29

Anti-hyperactivity medication: methylphenidate and amphetamine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.29

Growth of hyperactive children on maintenance regimen of methylphenidate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.29

Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.29

Drug metabolism in malnutrition and obesity: clinical concerns

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.29

Volume of food consumed affects satiety in men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.29

Titrating methylphenidate in children with attention-deficit/hyperactivity disorder: is body mass predictive of clinical response?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.29

Clinical studies of methylphenidate serum levels in children and adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.29

Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.29

Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.29

Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.29

Burst firing in midbrain dopaminergic neurons

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.29

Behavioural microanalysis of the role of dopamine in amphetamine anorexia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.29

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.29

Incorporating biomarkers of exposure and genetic susceptibility into smoking cessation treatment: effects on smoking-related cognitions, emotions, and behavior change

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.29

inferred from DOI database lookup

7 January 2021

based on heuristic

Mechanism of action of methylphenidate: insights from PET imaging studies

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.29

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/OBY.2004.29

1 reference

6 December 2017

1 reference